Our Proven Applications
Enhancing Each Stage of the Drug Development Process
From translational and exploratory research to global commercialization.
Gain depth and clarity. Our platform identifies novel biomarkers and analyzes new associations to create important insights about mechanism of action, pharmacodynamics, patient selection and stratification.
Clinical Trial Services
Drive clinical trial success. Confidently incorporate AI-based pathology biomarkers into prospective clinical trials for accurate patient selection, stratification and real time assessments of drug activity. Data is generated at scale, and in partnership with CRO and Central Laboratories, as well as under appropriate fit-for-purpose GxP, FDA and CLIA regulations.
CDx and Qualified Biomarker Development
Expand your footprint. Our medical device capabilities allow for regulated development of algorithms for targeted therapies across disease areas and biopharma portfolios. Our platform leverages partnerships with clinical labs and device manufacturers for global commercialization.
Transform Pathology with PathAI
Reach out to learn more about our contributor network opportunities.